Apo E genotyping by restriction fragment length polymorphism in myocardial infarct survivors and healthy controls

Simple item page
dc.contributor.authorHergenç, Gülay
dc.contributor.authorBudak, Yasemin
dc.contributor.authorTaga, Yavuz
dc.contributor.buuauthorİlçöl, Yeşim
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Biyokimya Anabilim Dalı.tr_TR
dc.contributor.researcheridAAL-8873-2021tr_TR
dc.date.accessioned2022-01-03T08:55:25Z
dc.date.available2022-01-03T08:55:25Z
dc.date.issued1999-11
dc.identifier.citationHergenç, G. vd. (1999). "Apo E genotyping by restriction fragment length polymorphism in myocardial infarct survivors and healthy controls". Clinical Chemistry, 45(11), 2050-2050.en_US
dc.identifier.endpage2050tr_TR
dc.identifier.issn0009-9147
dc.identifier.issue11tr_TR
dc.identifier.startpage2050tr_TR
dc.identifier.urihttp://hdl.handle.net/11452/23811
dc.identifier.volume45tr_TR
dc.identifier.wos000083440300055tr_TR
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherOxford University Pressen_US
dc.relation.collaborationYurt içitr_TR
dc.relation.journalClinical Chemistryen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectMedical laboratory technologyen_US
dc.subject.wosMedical laboratory technologyen_US
dc.titleApo E genotyping by restriction fragment length polymorphism in myocardial infarct survivors and healthy controlsen_US
dc.typeArticle
dc.wos.quartileQ1en_US

Files

License bundle
Now showing 1 - 1 of 1
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Web of Science